Skip to main content
TipRanks
Go Ultimate75% OFF

Cavan Redmond Insider Profile

4 Followers

Cavan Redmond, Director at Insight Molecular Diagnostics, holds 120.86K shares in Insight Molecular Diagnostics (Ticker: IMDX), holds ― shares in Lineage Therap (Ticker: LCTX), holds 45.00K shares in WebMD Health (Ticker: WBMD).

Cavan Redmond's Trading History

IMDX
Insight Molecular Diagnostics
Jul 19, 2022DirectorUninformative Buy10.20K$300.95K
WBMD
WebMD Health
Jun 28, 2012―Uninformative Buy―$2.99M
PFE
Pfizer
Feb 27, 2012Group PresidentUninformative Buy―$5.44M
LCTX
Lineage Therap
―Director――

You May Also Like

Cavan Redmond insider profile FAQ

What stocks does Cavan Redmond hold?
Cavan Redmond holds: IMDX, LCTX, PFE, WBMD stocks.
What was Cavan Redmond’s latest transaction?
Cavan Redmond’s latest transaction was an Uninformative Buy of $10.20K.
What is Cavan Redmond's role in Insight Molecular Diagnostics?
Cavan Redmond's role in Insight Molecular Diagnostics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.